JP2017511377A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017511377A5 JP2017511377A5 JP2017501145A JP2017501145A JP2017511377A5 JP 2017511377 A5 JP2017511377 A5 JP 2017511377A5 JP 2017501145 A JP2017501145 A JP 2017501145A JP 2017501145 A JP2017501145 A JP 2017501145A JP 2017511377 A5 JP2017511377 A5 JP 2017511377A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- disease
- compounds
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461968595P | 2014-03-21 | 2014-03-21 | |
| US61/968,595 | 2014-03-21 | ||
| PCT/US2015/022058 WO2015143447A2 (en) | 2014-03-21 | 2015-03-23 | Methods for treating neurological disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019012873A Division JP2019065044A (ja) | 2014-03-21 | 2019-01-29 | 神経疾患を治療するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017511377A JP2017511377A (ja) | 2017-04-20 |
| JP2017511377A5 true JP2017511377A5 (OSRAM) | 2018-03-29 |
| JP6588962B2 JP6588962B2 (ja) | 2019-10-09 |
Family
ID=54145492
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017501145A Active JP6588962B2 (ja) | 2014-03-21 | 2015-03-23 | 神経疾患を治療するための方法 |
| JP2019012873A Withdrawn JP2019065044A (ja) | 2014-03-21 | 2019-01-29 | 神経疾患を治療するための方法 |
| JP2020066670A Withdrawn JP2020109123A (ja) | 2014-03-21 | 2020-04-02 | 神経疾患を治療するための方法 |
| JP2022131705A Pending JP2022159555A (ja) | 2014-03-21 | 2022-08-22 | 神経疾患を治療するための方法 |
| JP2024205572A Pending JP2025022992A (ja) | 2014-03-21 | 2024-11-26 | 神経疾患を治療するための方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019012873A Withdrawn JP2019065044A (ja) | 2014-03-21 | 2019-01-29 | 神経疾患を治療するための方法 |
| JP2020066670A Withdrawn JP2020109123A (ja) | 2014-03-21 | 2020-04-02 | 神経疾患を治療するための方法 |
| JP2022131705A Pending JP2022159555A (ja) | 2014-03-21 | 2022-08-22 | 神経疾患を治療するための方法 |
| JP2024205572A Pending JP2025022992A (ja) | 2014-03-21 | 2024-11-26 | 神経疾患を治療するための方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10471029B2 (OSRAM) |
| EP (2) | EP4289820A3 (OSRAM) |
| JP (5) | JP6588962B2 (OSRAM) |
| KR (2) | KR102645633B1 (OSRAM) |
| CN (1) | CN106170563A (OSRAM) |
| AU (1) | AU2015230972B2 (OSRAM) |
| CA (1) | CA2941415A1 (OSRAM) |
| DK (1) | DK3119911T3 (OSRAM) |
| ES (1) | ES2960625T3 (OSRAM) |
| FI (1) | FI3119911T3 (OSRAM) |
| HR (1) | HRP20231172T1 (OSRAM) |
| HU (1) | HUE063369T2 (OSRAM) |
| LT (1) | LT3119911T (OSRAM) |
| PL (1) | PL3119911T3 (OSRAM) |
| PT (1) | PT3119911T (OSRAM) |
| RS (1) | RS64744B1 (OSRAM) |
| SI (1) | SI3119911T1 (OSRAM) |
| SM (1) | SMT202300369T1 (OSRAM) |
| WO (1) | WO2015143447A2 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6789579B2 (ja) * | 2015-09-10 | 2020-11-25 | アルジオン， インコーポレイテッド | 特定の患者集団において神経変性障害を処置する方法 |
| EP3485892B1 (en) * | 2016-07-13 | 2021-10-13 | Mitos Co., Ltd. | Composition for prevention or treatment of mild cognitive impairment or dementia containing hydrogen as active ingredient |
| CN108623501B (zh) * | 2017-03-21 | 2022-04-19 | 润佳（苏州）医药科技有限公司 | 同位素富集的3-氨基-1-丙磺酸衍生物及其用途 |
| CN110003058B (zh) | 2018-01-04 | 2022-01-25 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-3,3-二氘-1-丙磺酸晶型、制备方法及用途 |
| CN110668980A (zh) * | 2018-07-03 | 2020-01-10 | 浙江京新药业股份有限公司 | 一种2-取代的高牛磺酸衍生物 |
| US12285400B2 (en) * | 2018-08-01 | 2025-04-29 | Alzheon, Inc. | Sulfopropanoic acid derivatives for treating neurodegenerative disorders |
| DK3829563T3 (en) * | 2018-08-01 | 2025-02-24 | Alzheon Inc | 3-sulfopropanoic acid for treating neurodegenerative disorders |
| CN111170901A (zh) * | 2018-11-13 | 2020-05-19 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-1-丙磺酸晶型、制备方法及其用途 |
| CA3144008A1 (en) | 2019-06-17 | 2020-12-24 | Alzheon, Inc. | Methods for treating neurodegenerative disorders |
| CN112791078B (zh) | 2019-11-13 | 2022-12-06 | 润佳（苏州）医药科技有限公司 | 同位素富集的3-氨基-1-丙磺酸及其衍生物的用途 |
| EP4514335A1 (en) | 2022-04-28 | 2025-03-05 | Alzheon, Inc. | Tramiprosate for treating apoe4-related diseases |
| KR20250110352A (ko) | 2022-12-02 | 2025-07-18 | 알제온, 인크. | 트라미프로세이트를 이용하여 신경퇴행성 장애를 치료하는 방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| FI951701L (fi) * | 1992-10-13 | 1995-04-10 | Univ Duke | Menetelmät Alzheimerin taudin tunnistamiseksi |
| US20050031651A1 (en) | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US20050142191A1 (en) | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20060079578A1 (en) * | 2003-06-23 | 2006-04-13 | Julie Laurin | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20070010573A1 (en) | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
| CN1867795B (zh) | 2003-08-11 | 2010-12-08 | 加州理工学院 | 微流体的大规模集成 |
| PT2089417E (pt) | 2006-10-12 | 2015-04-14 | Bhi Ltd Partnership | Métodos, compostos, composições e veículos para administrar o ácido 3-amino-1-propanossulfónico |
| BRPI0719379A2 (pt) | 2006-11-24 | 2014-02-11 | Ac Immune Sa | Composto, composição farmacêutica, uso de composto, mistura, métodos para coletar dados para o diagnóstico de uma doença ou condição associada com amilóide em uma amostra ou um paciente, para determinar a extensão da carga de placa amiloidogênica em um tecido e/ou um fluido corporal, para coletar dados para determinar a predisposição a uma doença ou condição associada com amilóide em um paciente, para coletar dados para monitorar a doença residual mínima em um paciente seguindo o tratamento com um anticorpo ou uma composição de vacina e para coletar dados para predizer a responsividade de um paciente sendo tratado com um anticorpo ou uma composição de vacina, e, kit de teste |
| WO2012006329A2 (en) * | 2010-07-06 | 2012-01-12 | Genomind, Llc | Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| DK2605655T3 (en) | 2010-08-19 | 2019-02-04 | Buck Institute For Age Res | METHODS OF TREATING SMALL COGNITIVE DISABILITY (MCI) AND RELATED DISORDERS |
| AU2014262890B2 (en) | 2013-05-06 | 2019-01-31 | Takeda Pharmaceutical Company Limited | Treatment of Alzheimer's disease subpopulations with pooled immunoglobulin G |
| NZ723884A (en) * | 2014-02-08 | 2023-02-24 | Genentech Inc | Methods of treating alzheimer’s disease |
| JP6789579B2 (ja) | 2015-09-10 | 2020-11-25 | アルジオン， インコーポレイテッド | 特定の患者集団において神経変性障害を処置する方法 |
| US20180250249A1 (en) | 2016-02-02 | 2018-09-06 | Alzheon, Inc. | Methods of treating neurodegenerative disorders in a particular population |
-
2015
- 2015-03-23 EP EP23189240.7A patent/EP4289820A3/en active Pending
- 2015-03-23 FI FIEP15764560.7T patent/FI3119911T3/fi active
- 2015-03-23 SM SM20230369T patent/SMT202300369T1/it unknown
- 2015-03-23 KR KR1020227033161A patent/KR102645633B1/ko active Active
- 2015-03-23 RS RS20230993A patent/RS64744B1/sr unknown
- 2015-03-23 DK DK15764560.7T patent/DK3119911T3/da active
- 2015-03-23 AU AU2015230972A patent/AU2015230972B2/en active Active
- 2015-03-23 HR HRP20231172TT patent/HRP20231172T1/hr unknown
- 2015-03-23 CA CA2941415A patent/CA2941415A1/en active Pending
- 2015-03-23 WO PCT/US2015/022058 patent/WO2015143447A2/en not_active Ceased
- 2015-03-23 JP JP2017501145A patent/JP6588962B2/ja active Active
- 2015-03-23 EP EP15764560.7A patent/EP3119911B1/en active Active
- 2015-03-23 PT PT157645607T patent/PT3119911T/pt unknown
- 2015-03-23 HU HUE15764560A patent/HUE063369T2/hu unknown
- 2015-03-23 CN CN201580015086.8A patent/CN106170563A/zh active Pending
- 2015-03-23 LT LTEPPCT/US2015/022058T patent/LT3119911T/lt unknown
- 2015-03-23 US US15/127,565 patent/US10471029B2/en active Active
- 2015-03-23 PL PL15764560.7T patent/PL3119911T3/pl unknown
- 2015-03-23 ES ES15764560T patent/ES2960625T3/es active Active
- 2015-03-23 KR KR1020167027090A patent/KR102448386B1/ko active Active
- 2015-03-23 SI SI201531967T patent/SI3119911T1/sl unknown
-
2019
- 2019-01-29 JP JP2019012873A patent/JP2019065044A/ja not_active Withdrawn
- 2019-09-13 US US16/570,487 patent/US20200101031A1/en not_active Abandoned
-
2020
- 2020-04-02 JP JP2020066670A patent/JP2020109123A/ja not_active Withdrawn
-
2022
- 2022-07-29 US US17/877,380 patent/US20230087041A1/en active Pending
- 2022-08-22 JP JP2022131705A patent/JP2022159555A/ja active Pending
-
2024
- 2024-11-26 JP JP2024205572A patent/JP2025022992A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017511377A5 (OSRAM) | ||
| JP2020097577A5 (OSRAM) | ||
| JP2016521119A5 (OSRAM) | ||
| JP2015024998A5 (OSRAM) | ||
| JP2019516739A5 (OSRAM) | ||
| JP2016516074A5 (OSRAM) | ||
| JP2012504133A5 (OSRAM) | ||
| JP2017520613A5 (OSRAM) | ||
| JP2017528503A5 (OSRAM) | ||
| JP2017514910A5 (OSRAM) | ||
| JP2013507415A5 (OSRAM) | ||
| JP2016539134A5 (OSRAM) | ||
| JP2018529698A5 (OSRAM) | ||
| JP2015508103A5 (OSRAM) | ||
| JP2010501534A5 (OSRAM) | ||
| JP2011518833A5 (OSRAM) | ||
| FI3119911T3 (fi) | Yhdisteitä käytettäväksi alzheimerin taudin hoitamisessa apoe4+/+-potilaissa | |
| JP2016522254A5 (OSRAM) | ||
| JP2014513136A5 (OSRAM) | ||
| JP2019529514A5 (OSRAM) | ||
| JP2016510326A5 (OSRAM) | ||
| JP2010521516A5 (OSRAM) | ||
| JP2016539157A5 (OSRAM) | ||
| JP2018530608A5 (OSRAM) | ||
| JP2019535760A5 (ja) | ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法 |